Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Study of ImmunoPet Imaging of PD-L1 in Tumors Using 89Zr-DFO-REGN3504 in Patients With Advanced Thoracic Malignancies or Hepatocellular Carcinoma

Study of ImmunoPet Imaging of PD-L1 in Tumors Using 89Zr-DFO-REGN3504 in Patients With Advanced Thoracic Malignancies or Hepatocellular Carcinoma
Conditions:   Advanced Thoracic Malignancies;   Hepatocellular Carcinoma;   Gastroesophageal Junction Adenocarcinoma;   Gastric Cancer
Intervention:   Drug: 89Zr˗DFO˗REGN3504
Sponsor:   Regeneron Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 26, 2019 / by / in
Comments